サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1111414

酸素療法市場 : 世界の産業動向、シェア、規模、成長、機会、2022-2027年予測

Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
酸素療法市場 : 世界の産業動向、シェア、規模、成長、機会、2022-2027年予測
出版日: 2022年08月04日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の酸素療法市場規模は、2021年に164億米ドルに達しました。今後、IMARCグループは、2022年から2027年の間に8.1%の成長率（CAGR）を示し、2027年までに255億米ドルに達すると予測しています。COVID-19の不確実性を念頭に置き、我々はパンデミックが様々な最終使用部門に及ぼす直接的および間接的な影響を継続的に追跡・評価しています。これらの洞察は、市場の主要な貢献者としてレポートに含まれています。

酸素療法（または補助酸素）は、血中酸素濃度を管理し、一酸化炭素中毒を予防するために追加の酸素源を使用する医療行為を指します。低酸素症、低酸素血症、肺炎、喘息などの症状に対して一般的に使用されます。酸素は液体または気体の形で投与され、カニューレやフェイスマスク、高気圧酸素室から送り込まれます。また、人工呼吸器や持続陽圧呼吸器など他の医療機器に取り付けて、治療の効率化を図ることもあります。また、ヘルスケアセンターでは、患者にポイントオブケア（POC）と便利な酸素療法治療を提供するために、新しい携帯用タンクと酸素濃縮器を使用しています。

肺炎、嚢胞性線維症、喘息、形成不全、睡眠時無呼吸症候群など、さまざまな呼吸器系疾患が世界中で増加していることは、市場成長に明るい展望をもたらす重要な要因の1つとなっています。酸素療法は、肺胞から血液への酸素の移動、細胞の代謝、組織の酸素化を改善し、正常な生理機能を維持するために行われます。さらに、ニコチンやタバコ製品の消費量の増加や、こうした病気にかかりやすい老年人口の増加が、市場成長の推進力となっています。さらに、費用対効果が高く、迅速かつ正確な酸素療法機器の開発や、医師、外科医、患者の間で酸素療法への嗜好が高まっていることも、市場に明るい展望を生み出しています。その他の要因としては、医療費負担の増加、広範な研究開発（R&D）活動などがあり、市場をさらに押し上げると予想されます。

主な市場セグメンテーション

  • IMARC Groupは、酸素療法の世界市場レポートにおいて、各サブセグメントにおける主要動向の分析と、2022～2027年の世界、地域、国レベルでの予測を提供しています。当レポートでは、製品、用途、最終用途に基づき、市場を分類しています。

製品別の内訳

  • 酸素源装置
  • 酸素ボンベ
  • 酸素濃縮器
  • 液体酸素装置
  • PAP装置
  • 酸素供給装置
  • 酸素マスク
  • 鼻腔用カニューレ
  • ベンチュリーマスク
  • ノンリブリーザーマスク
  • バッグバルブマスク
  • CPAPマスク
  • その他

アプリケーション別の内訳

  • 慢性閉塞性肺疾患領域
  • 喘息
  • 閉塞性睡眠時無呼吸症候群
  • 呼吸窮迫症候群
  • 嚢胞性線維症
  • 肺炎
  • その他

エンドユーザー別の内訳

  • 在宅ヘルスケア
  • 病院

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • 酸素療法の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのでしょうか？
  • COVID-19は世界の酸素療法市場にどのような影響を及ぼしましたか？
  • 主要な地域別市場はどのようなものか？
  • 製品に基づく市場の区分は？
  • 用途別の市場内訳は？
  • 最終用途に基づく市場の区分は？
  • 業界のバリューチェーンにおける様々なステージとは？
  • 業界における主要な推進要因と課題は何か？
  • 世界の酸素療法市場の構造と主要プレイヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 酸素療法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品別市場内訳

  • 酸素源装置
    • 市場動向
    • 主要セグメント
      • 酸素ボンベ
      • 酸素濃縮器
      • 液体酸素装置
      • PAP装置
    • 市場予測
  • 酸素供給装置
    • 市場動向
    • 主要セグメント
      • 酸素マスク
      • 鼻腔用カニューレ
      • ベンチュリーマスク
      • ノンリブリーザーマスク
      • バッグバルブマスク
      • CPAPマスク
      • その他
    • 市場予測

第7章 アプリケーション別市場内訳

  • 慢性閉塞性肺疾患分野
    • 市場動向
    • 市場予測
  • 喘息
    • 市場動向
    • 市場予測
  • 閉塞性睡眠時無呼吸症候群
    • 市場動向
    • 市場展望
  • 呼吸窮迫症候群
    • 市場動向
    • 市場予測
  • 嚢胞性線維症
    • 市場動向
    • 市場予測
  • 肺炎
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • ホームヘルスケア
    • 市場動向
    • 市場予測
  • 病院
    • 市場動向
    • 市場展望

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場展望
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC（Drive Medical Inc.）
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips N.V
    • Smiths Group plc
    • Tecno-Gaz S.p.A.
    • Teleflex Incorporated
図表

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2021
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2021
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2021
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2021
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2021
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million US$), 2022-2027
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million US$), 2022-2027
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million US$), 2022-2027
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players
目次
Product Code: SR0822A112_Report

The global oxygen therapy market size reached US$ 16.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 25.5 Billion by 2027, exhibiting a growth rate (CAGR) of 8.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Oxygen therapy, or supplemental oxygen, refers to a medical treatment that involves using an additional oxygen source to manage the blood oxygen levels and prevent carbon monoxide toxicity. It is commonly used for conditions, such as hypoxia, hypoxemia, pneumonia and asthma. Oxygen is administered in liquid or gaseous form, which is transferred through a cannula, face mask or hyperbaric oxygen chamber. They are also attached to other medical devices, such as ventilators and continuous positive airway pressure machines, to improve the efficiency of the treatment. Healthcare centers are also using novel portable tanks and oxygen concentrators to provide point-of-care (POC) and convenient oxygen therapy treatments to the patients.

The increasing prevalence of various respiratory disorders, such as pneumonia, cystic fibrosis, asthma, dysplasia and sleep apnea, across the globe is one of the key factors creating a positive outlook for the market growth. Oxygen therapy is used to improve the transfer of oxygen from alveoli to the blood, cell metabolism and tissue oxygenation, which are essential for normal physiological functioning. Furthermore, increasing consumption of nicotine and tobacco products, along with the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Additionally, the development of cost-effective, rapid and accurate oxygen therapy devices and the increasing preference for oxygen therapy among doctors, physicians, surgeons and patients are also creating a positive outlook for the market. Other factors, including rising healthcare expenditure capacities, along with extensive research and development (R&D) activities, are anticipated to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygen therapy market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end use.

Breakup by Product:

  • Oxygen Source Equipment
  • Oxygen Cylinders
  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • PAP Devices
  • Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others

Breakup by Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others

Breakup by End Use:

  • Home Healthcare
  • Hospitals

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A., and Teleflex Incorporated.

Key Questions Answered in This Report:

  • How has the global oxygen therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oxygen therapy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oxygen therapy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis